Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris.

[1]  J. Parker.  Eccentric dosing with isosorbide-5-mononitrate in angina pectoris. , 1993, The American journal of cardiology.

[2]  J. Wei,et al.  Age and the cardiovascular system. , 1992, The New England journal of medicine.

[3]  R. Busse,et al.  Role of Endothelium‐Derived Bradykinin in the Control of Vascular Tone , 1992, Journal of cardiovascular pharmacology.

[4]  G. Jackson,et al.  Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina , 1991, The Lancet.

[5]  S. Savonitto,et al.  Twenty-four-hour activity of felodipine extended release in chronic stable angina pectoris. , 1991, The American journal of cardiology.

[6]  P. Kopelman,et al.  Aging, autonomic function, and the perception of angina. , 1991, British heart journal.

[7]  J. Wei,et al.  Reversal of changes in left ventricular diastolic filling associated with normal aging using diltiazem. , 1991, The American journal of cardiology.

[8]  R S Woodward,et al.  The effect of prescribed daily dose frequency on patient medication compliance. , 1990, Archives of internal medicine.

[9]  J. Alpert,et al.  Nitrate therapy in the elderly. , 1990, The American journal of cardiology.

[10]  R. Zelis,et al.  Aging reduces venous distensibility and the venodilatory response to nitroglycerin in normal subjects. , 1989, The American journal of cardiology.

[11]  M. Alpert,et al.  The clinical description of angina pectoris in the elderly. , 1989, American heart journal.

[12]  K. Jennings,et al.  The effects of treatment with felodipine as a single agent in coronary artery disease. , 1989, British heart journal.

[13]  A Pomerance,et al.  Human aging: changes in structure and function. , 1987, Journal of the American College of Cardiology.

[14]  J. Parker.  Nitrate therapy in stable angina pectoris. , 1987, The New England journal of medicine.

[15]  A. Veld.  Effect of beta blockers on vascular resistance in systemic hypertension , 1987 .

[16]  P. Routledge,et al.  Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris. , 1987, British journal of clinical pharmacology.

[17]  E. Antman,et al.  Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise. , 1985, The American journal of cardiology.

[18]  E. K. Weir,et al.  "Maximal" drug therapy is not necessarily optimal in chronic angina pectoris. , 1984, Journal of the American College of Cardiology.

[19]  G. Johnsson,et al.  The systemic and coronary haemodynamic effects of felodipine in patients with coronary heart disease. , 1983, European heart journal.

[20]  C. Lassvik.  Reproducibility of work performance at serial exercises in patients with angina pectoris. , 1978, Scandinavian journal of clinical and laboratory investigation.

[21]  K Hirschhorn,et al.  Letter: Immunotherapy for colorectal cancer. , 1976, Lancet.

[22]  V. Barnett,et al.  Applied Linear Statistical Models , 1975 .

[23]  D. Faulds,et al.  Felodipine , 2012, Drugs.

[24]  J. Cruickshank.  Beta-blockers: primary and secondary prevention. , 1992, Journal of cardiovascular pharmacology.

[25]  A. Marmor,et al.  Comparative evaluation of the effect of afterload- and preload-reducing drugs on diastolic cardiac function in hypertensive patients. , 1991, Cardiology.

[26]  J. Morley,et al.  Clinical implications of the aging heart. , 1989, The American journal of medicine.

[27]  G. Borg.  Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.

[28]  H. Russek.  Propranolol and isosorbide dinitrate synergism in angina pectoris. , 1968, The American journal of cardiology.